Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1989-10-26
|
pubmed:abstractText |
Cultured rat and ovine anterior pituitary cells were treated with a range of doses (0.01-1,000 nM) of arginine vasopressin (AVP) and ovine corticotropin-releasing factor (CRF), alone or in combination, and medium and cell content of immunoreactive (ir-)ACTH determined. In rat cells, a dose-response curve to CRF was obtained, with a threshold dose of 0.1 nM; AVP was much less effective alone, but augmented CRF responses when administered with CRF. In ovine pituitary cells AVP markedly stimulated ACTH release in a dose-dependent fashion, and with a threshold of 0.1 nM; in contrast, CRF increased ACTH release over basal only at doses greater than 100 nM. In combination, subthreshold doses of AVP potentiated rat pituitary cell responses to CRF; addition of 1 nM of AVP to varying doses of CRF was more effective in terms of ACTH release than addition of 1 nM of CRF to increasing doses of AVP. In contrast, in ovine cells the addition of 1 nM CRF to increasing doses of AVP elicited a larger ACTH response than the addition of 1 nM AVP to increasing doses of CRF. Dexamethasone pretreatment (5 nM) for 48 h significantly decreased CRF potentiation of AVP-stimulated ACTH release in ovine cells. These studies confirm that CRF is a more potent stimulus of ACTH release than AVP in the rat, and establish that in contrast AVP is a much more potent stimulus of ACTH secretion than CRF in isolated ovine pituitary cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenocorticotropic Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Arginine Vasopressin,
http://linkedlifedata.com/resource/pubmed/chemical/Corticotropin-Releasing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0028-3835
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
152-7
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2550836-Adrenocorticotropic Hormone,
pubmed-meshheading:2550836-Animals,
pubmed-meshheading:2550836-Arginine Vasopressin,
pubmed-meshheading:2550836-Cells, Cultured,
pubmed-meshheading:2550836-Corticotropin-Releasing Hormone,
pubmed-meshheading:2550836-Dexamethasone,
pubmed-meshheading:2550836-Dose-Response Relationship, Drug,
pubmed-meshheading:2550836-Drug Synergism,
pubmed-meshheading:2550836-Female,
pubmed-meshheading:2550836-Male,
pubmed-meshheading:2550836-Pituitary Gland, Anterior,
pubmed-meshheading:2550836-Rats,
pubmed-meshheading:2550836-Rats, Inbred Strains,
pubmed-meshheading:2550836-Sheep,
pubmed-meshheading:2550836-Stress, Physiological
|
pubmed:year |
1989
|
pubmed:articleTitle |
Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. 1. In vitro studies.
|
pubmed:affiliation |
Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|